Investigating dementia in individuals with a history of incarceration
Official title: Alzheimer’s Disease and Related Dementias in The Most Incarcerated Generation: An Understudied Population with Health Disparities
Funded at Northern California Institute/res/edu · NIH-11051195 · Data updated 2026-11-12
This study is looking at how being in jail might affect the brain health of older veterans, especially those who have lived in different communities, and it wants to understand how things like race and income play a role in their risk for dementia.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Northern California Institute/res/edu NIH-funded |
| Lab location | 1 site (San Francisco, United States) |
| Project start | April 1, 2023 |
| Project end | March 31, 2028 |
| Funding year | 2025 |
| Award (this year) | $730,481 |
| NIH project number | 5R01AG082157-03 |
| Project ID | NIH-11051195 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are veterans aged 50 and older who have a history of incarceration.
✕Less likely to help
Patients who have never been incarcerated or are younger than 50 years old may not benefit from this research.
What this research studies
This research examines the connection between incarceration and dementia, focusing on individuals who have transitioned between community living and incarceration. It aims to understand how factors like race and socioeconomic status contribute to health disparities in dementia among this population. By analyzing a large cohort of veterans aged 50 and older who have experienced incarceration, the study will explore the impact of these experiences on their cognitive health over time. The research utilizes data from the Veterans Health Administration and Medicare to track health outcomes.
Why it matters
Potential benefit: If successful, this research could lead to improved understanding and interventions for dementia in marginalized populations, ultimately enhancing care and support for affected individuals.
How similar studies have gone: While this research addresses a unique population, similar studies have shown that understanding health disparities can lead to significant improvements in care for underserved groups.
Where this research is happening
-
Northern California Institute/res/edu
San Francisco, United States Active
Researchers
- Principal investigator: Byers, Amy Lynn — Northern California Institute/res/edu
- Study coordinator: Byers, Amy Lynn
Related research
Other NIH-funded projects on the same topics.
-
Understanding how brain activity changes may drive Alzheimer’s disease progression in a mouse model
Researchers are testing how changes in brain signals and protein cleanup processes affect the development of Alzheimer’s disease in mice.
-
Thiamine-boosting therapy for Alzheimer’s: understanding how benfotiamine may reduce harmful AGE in DP patients
A medication-based approach using high-dose vitamin B1 (benfotiamine) is studied to help people with Alzheimer's by reducing harmful sugar-related molecules.
-
Non-invasive tears biomarker for early Alzheimer's in LMICs
A low-cost, tear-based biomarker approach aims to detect early Alzheimer’s disease in older adults in Peru and similar settings.
-
Turning APOE4 into protective APOE2 or APOE3Christchurch to help with Alzheimer’s
A patient-facing explanation of a treatment idea that aims to change a genetic risk factor for Alzheimer's disease in the brain.
-
Telomerase in Alzheimer’s Disease: how aging biology could influence memory and brain health
Researchers are exploring a new brain-aging mechanism linked to telomerase, with potential to slow or modify Alzheimer’s disease in people and improve cognitive function.
-
Biomarkers of Alzheimer’s Disease: Sensory, Motor, and Cognitive Clues
Researchers are testing simple sensory and movement tasks to find early signs of Alzheimer’s disease so they can diagnose and treat people sooner.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.